Steven Bartlett with Dr Thomas Seyfried
Cancer is fundamentally a metabolic disorder driven by mitochondrial dysfunction rather than a genetic disease. The traditional medical establishment views cancer as a consequence of genetic mutations in the cell nucleus. However, the origin of cancer actually lies in the chronic damage to the mitochondria, which are the energy-producing organelles inside cells. When the mitochondria lose their ability to generate energy efficiently using oxygen, the cell is forced to adapt to survive.
To maintain energy production, the damaged cell reverts to an ancient, inefficient biological pathway known as fermentation. This transition from oxidative phosphorylation to fermentation is the core pathophysiological problem shared by all forms of cancer, whether located in the brain, breast, or colon. The cells begin to grow out of control because they are locked into this primitive energy cycle, constantly consuming specific fermentable fuels to stay alive.
Cancer cells rely entirely on two primary fuels to sustain their rapid, unregulated growth: glucose and the amino acid glutamine. Because their mitochondria are defective, tumor cells cannot process these fuels completely. Instead, they ferment glucose into lactic acid and glutamine into succinic acid. These waste products build up in the microenvironment, signaling that the cells are generating energy without oxygen.
As long as high levels of glucose and glutamine remain available in the bloodstream, tumor cells will continue to thrive and multiply. The cells act much like ancient organisms that existed billions of years ago before Earth had an oxygen-rich atmosphere. They will consume all available fermentable fuels and replicate relentlessly until the energy supply is deliberately cut off.
The prevailing belief that genetic mutations cause cancer is contradicted by nuclear transfer experiments. Scientists have taken the nucleus from a malignant tumor cell and placed it into a healthy cell with normal mitochondria. The result is perfectly regulated, healthy cell growth. Conversely, taking a healthy nucleus and placing it into a tumor cell with defective mitochondria results in the same dysregulated tumor growth.
This proves that the nucleus and its genetic mutations are not the drivers of the disease. Furthermore, many tumor cells exhibit zero genetic mutations, while normal, healthy tissues often contain numerous mutations without ever developing into tumors. The genetic defects observed in cancer cells are actually downstream effects. The defective mitochondria produce reactive oxygen species, which then cause the very DNA mutations that researchers mistakenly identify as the root cause of the disease.
The destruction of mitochondrial function does not happen overnight. It is the result of chronic, cumulative damage caused by environmental and lifestyle factors. Our evolutionary ancestors rarely developed cancer because their environments naturally kept their mitochondria healthy. Today, human biology is overwhelmed by highly processed carbohydrates, chemical carcinogens, microplastics, chronic mental stress, and a severe lack of physical exercise.
These provocative agents trigger inflammation and disrupt oxidative respiration within the cells. For example, a localized accumulation of foreign materials like talcum powder forces the immune system to deploy cytokines, which unintentionally damages nearby mitochondria. When multiple destructive lifestyle factors converge, they force cell populations to abandon oxygen-based energy production and permanently upregulate fermentation.
Because cancer cells cannot survive without glucose and glutamine, restricting these fuels starves the tumor. Metabolic therapy simultaneously lowers blood sugar levels and transitions the entire body to run on fatty acids and ketone bodies. Ketones act as a highly efficient, water-soluble super fuel for the brain, heart, and normal tissues. Healthy cells with intact mitochondria easily adapt to burning ketones for energy.
Tumor cells lack the metabolic flexibility to use ketones because their mitochondria are severely corrupted. By enforcing nutritional ketosis through carbohydrate restriction and targeted fasting, the body selectively marginalizes the cancer cells. The tumors gradually shrink and die off while the surrounding healthy tissues become increasingly energized and highly resilient.
To successfully implement metabolic therapy, individuals must precisely track their internal environment using the Glucose Ketone Index. This metric is calculated by dividing blood glucose levels by blood ketone levels. Maintaining an index of 2.0 or below indicates that the body has entered a deep state of nutritional ketosis, effectively mimicking the natural biological state of early human ancestors.
Operating within this physiological zone actively suppresses tumor growth. It provides a measurable, quantitative target for patients attempting to manage their disease without toxic interventions. For healthy individuals, maintaining a low index serves as a powerful preventative strategy, guaranteeing that mitochondria remain healthy and robust enough to resist the metabolic transition that causes cancer.
Standard cancer treatments like radiation and chemotherapy often inflict catastrophic damage on the body while failing to improve overall survival rates. These approaches are designed to poison and irradiate tissue to slow tumor progression. However, procedures like brain irradiation actually explode the cells and flood the local microenvironment with massive amounts of glucose and glutamine, inadvertently providing surviving cancer cells with an abundance of their preferred fuel.
Certain conventional drugs create the illusion of success by temporarily stopping localized growth, but they simultaneously force the tumor to spread invasively throughout the entire organ. Furthermore, radiation generates intense reactive oxygen species that brutalize healthy cells and further degrade mitochondrial function. Patients who survive the initial cancer are frequently left with permanent adverse effects and an increased risk of secondary diseases caused by the treatments themselves.